A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia

Blood

Volumn 92, Issue 7, 1998, Pages 2315-2321

  Buño, Ismael ^b   Wyatt, William A ^b   Zinsmeister, Alan R ^b   Dietz Band, Jeanne ^b   Silver, Richard T ^b   Dewald, Gordon W ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032190169     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2315     Document Type: Article

References (21)

1. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Loffler H, Hochhaus A, Heinze B, Georgii A, Bartram CR, Griesshammer M, Bergmann L, Essers U, Falge C, Queisser U, Meyer P, Schmitz N, Eimermacher H, Walther F, Fett W, Kleeberg UR, Kubisch A, Nerl C, Zimmermann R, Meuret G, Tichelli A, Kanz L, Tiges F-J, Schmid L, Brockhaus W, Tobler A, Reiter A, Perker M, Emmerich B, Verpoort K, Zankovich R, von Wussow P, Prummer O, Thiele J, Buhr T, Carbonnell F, Ansari H, and the German CML Study Group: Randomized comparison of interferon-α with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood 84:4064, 1994
2. The Italian Cooperative Study Group on Chronic Myeloid Leukemia: Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 30:820, 1994
3. Allan NC, Richards SM, Shepherd PCA, on behalf of the UK Medical Research Council's Working Parts for Therapeutic Trials in Adult Leukaemia: Impact of Interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia. Br J Haematol 83:399, 1995
4. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M: Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. Ann Intern Med 122:254, 1995
5. Thaler J, Gastl G, Fluckinger T, Niederwieser D, Huber H, Seewann H, Sill H, Lang A, Falk M, Duba C, Utermann G, Kuhr T, Aulitzky W, Huber C: Austrian Biological Response Modifier (BRM) Study Group. Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: Long term results of a multicenter phase-II study. Ann Hematol 72:349, 1996
6. Tkachuk DC, Westbrook CA, Andreeff M, Donlon A, Cleary ML, Suryanaryan K, Homge M, Redneer A, Gray J, Pinkel D: Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 250:559, 1990
7. Arnoldus EP, Wiegant J, Noordermeer IA, Wessels JW, Beverstock GC, Grosveld GC, van der Ploeg M, Raap AK: Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet 54:108, 1990
8. Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeister AR, Spurbeck JL, Thibodeau S, Jalal SM: The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 71:7, 1993
9. Amiel A, Yarkoni S, Slavin S, Or R, Lorberboum GH, Fejgin M, Nagler A: Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization. Cancer Genet Cytogenet 76:59, 1994
10. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P, Dormer H: Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 83:1922, 1994
11. Mühlmann J, Thaler J, Hilbe W, Bechter O, Erdel M, Utermann G, Duba HC: Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: A new strategy for remission assessment. Genes Chromosomes Cancer 21:90, 1998
12. Cox Froncillo MC, Maffei L, Cantonetti M, Del Poeta G, Lentini R, Bruno A, Masi M, Tribalto M, Amadori S: FISH analysis for CML monitoring? Ann Hematol 73:113, 1996
13. Chase A, Grand F, Zhang Ji-Guang, Blackett N, Goldman J, Gordon M: Factors influencing the false positive and negative rates of BCR-ABL fluorescence in situ hybridization. Genes Chromosomes Cancer 18:246, 1997
14. Sinclair PB, Green AR, Grace C, Nacheva EP: Improved sensitivity of BCR-ABL detection: A triple-probe three-color fluorescence in situ hybridization system. Blood 90:1395, 1997
15. Dewald GW, Wyatt WA, Juneau AL, Carlson RO, Zinsmeister AR, Jalal SM, Spurbeck JL, Silver RT: Highly sensitive FISH method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood 91:3357, 1998
16. Spurbeck JL, Zinsmeister AR, Meyer KJ, Jalal SM: The dynamics of chromosome spreading. Am J Med Genet 61:387, 1996
17. Dewald GW, Juneau AL, Schad CR, Tefferi A: Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia. Cancer Genet Cytogenet 94:59, 1997
18. Seong DC, Kantarjian HM, Ro JY, Talpaz M, Xu J, Robinson JR, Deisseroth AB, Champlin RE, Siciliano MJ: Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment. Blood 86:2343, 1995
19. Littell RC, Milliken GA, Stroup WW, Wolfinger RD: SAS System for Mixed Models. Cary, NC, SAS Institute Inc, 1996, p 126
20. Tefferi A, Schad CR, Pruthi RK, Ahmann GJ, Spurbeck JL, Dewald GW: Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukaemia. Cancer Genet Cytogenet 83:61, 1995
21. Hicks GA, Dewald GW: Incidence and types of variant Ph chromosomes in 378 patients with a Ph chromosome. Proceedings of the 10th Annual National Meeting of the Association of Cytogenetic Technologists, Monterey, CA. Karyogram 11:105, 1985